An experimental study of phage mediated bactericidal selection & emergence of the El Tor Vibrio cholerae.
Historically, cholera is an ancient disease with the occurrence of seven distinct pandemics since the first pandemic of cholera recorded in 1817, but the disease still affects millions of people. V. cholerae O1 belongs to two biotypes, namely classical and El Tor which differ in certain phenotypic and genetic characteristics (4,5). The current 7th pandemic of cholera which originated in Indonesia in 1961 is the most extensive in geographic spread and duration, and the causative agent is V. cholerae O1 of the El Tor biotype. The classical biotype, which caused the 6th pandemic, is now presumably extinct. After a period during the 1970-1980 when both classical and El Tor strains coexisted, classical strains were last detected in southern Bangladesh in 1990 (6). However, factors associated with the replacement of the classical biotype as the predominant epidemic strain by the El Tor biotype, and eventual disappearance of the classical strains have not been adequately explained. The displacement of the classical strains by the El Tor might have been driven by undefined environmental forces to which the El Tor strains adapted more efficiently. For example, the propensity to form biofilms on aquatic surfaces, interactions with marine animals and plants, and the ability to resist acid production in carbohydrate metabolism are some of the possible determining factors (7-10) in this ecological competition.
The recent recognition that phage predation may play a role in the natural control of cholera epidemics (2,11,12) reinforces prediction that changes in this pathogen may also be driven by phages. The emergence of certain strains are likely to be enhanced by phages through the bactericidal mechanism in which phage sensitive strains are killed while providing a selective advantage to phage resistant strains. Therefore, the ability to evade phage predation constitutes important development in attaining evolutionary fitness. In the present study, we describe a bacteriophage which could have contributed to the range of factors causing the replacement of the 6th pandemic classical strains of V. cholerae with the El Tor strains causing the current 7th pandemic. We have also attempted to reproduce the conditions using microcosms and animal models, under which one or more phages might have acted in the events leading to the replacement of the classical biotype strains by the El Tor strains.
Material & Methods
Bacterial strains and phages: V. cholerae strains used as indicators in plaque assays or host for phage preparations were from either clinical or environmental sources. Clinical strains were obtained from patients who attended the treatment center of the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B) located in Dhaka or from the culture collection of ICDDR,B Environmental isolates were from surface waters in Dhaka. All V. cholerae strains were isolated between 1963 and 2009 and maintained in our collection.
Isolation and estimation of phage: A panel of V. cholerae O1 were used as potential indicator strains to detect and isolate classical biotype specific phage from environmental water using the plaque assay, as described previously (2,11). Plaques were counted to estimate the concentration of phage particles in the sample. Phages from representative plaques were further purified, and the specificity of each phage was tested using a panel of strains belonging to different Vibrio species and serotypes. For detection and quantification of phage in intestinal extracts of mice, aliquots of the samples were pre-filtered through 0.22 [micro]m pore size filters (Millipore Corporation, Bedford, MA) and dilutions of this filtrate were used in plaque assays. Animal studies were reviewed and approved by the Animal Experimental Ethics Committee of ICDDR B.
Phage stability: The effect of temperature, pH, and salinity on the stability of JSF9 phage was assessed by adding a defined number of phage particles into SM buffer (100 mM NaCl, 8 mM MgS[O.sub.4], 50 mM Tris-Cl, pH 7.5) adjusted to different conditions. The titre of phage particles remaining after 6 h was expressed as a percentage of the original titre.
Electron microcopy of phage particles: A high titre phage preparation [[~10.sup.10] plaque forming unit/ml] was obtained using the plate lysis procedure as described previously (13). The phage particle was negatively stained with 2 per cent uranyl acetate and was examined under a Philips transmission electron microscope (model 420T).
Determination of infectious dose (ID50) in mice: To determine the [ID.sub.50] of V. cholerae strains, 5-day-old Swiss Albino mice in groups of five were inoculated intragastrically with one or more laboratory grown V. cholerae strains, as well as with a mixture of V. cholerae and phage whenever appropriate. Aliquots of these samples were also cultured as described above to determine the cell count, and plaque assays were conducted to determine the concentration of phage. Mice were euthanized at 24 h and the small intestines were homogenized in phosphate buffered saline (PBS) pH 7.5. The homogenate was centrifuged and the pellet was re-suspended in fresh PBS, to eliminate possible phage particles (derived from phage positive samples) which could negatively influence the cell count. Dilutions of the suspension were then plated on taurocholate tellurite gelatine agar plates (14) (70 [micro]g/ ml) to determine the number of colony forming units (cfu) of bacteria. The percentage of infected mice was plotted against the input dose to determine the [ID.sub.50] as described previously (15,16).
Competition assays in animals and in water samples: To reproduce conditions under which phages might influence the selective enrichment or elimination of particular strains of pathogenic V. cholerae, we developed an assay system comprising repeated alternate inoculation of a mixture of V. cholerae strains and phage in animal models as well as in surface water samples. Competition assays were conducted by mixing 1:1 (v/v) ratio of the El Tor and classical biotype strains grown in Luria Bertini (LB) medium to log phase, and 106 plug forming units (pfu) of the classical biotype specific phage JSF9. Aliquots (50 [micro]l) of a 1,00-fold dilution of this mixture, were administered to 3-5-day-old Swiss Albino mice. A control preparation of the bacterial mixtures without the phage was also used in each batch of assay. Mice were euthanized at 24 h and the small intestines were homogenized in PBS. The homogenate was inoculated in filter-sterilized environmental water samples (1:100 dilution), and incubated at room temperature for 24 h. Aliquots (50 [micro]l) of this water samples were inoculated into a second batch of mice, and the process was repeated. After each passage, the relative concentrations of the two strains in the intestinal contents of mice, as well as in the water samples were determined by plating dilutions of the samples on nutrient agar plates containing an appropriate antibiotic. The V. cholerae strains could be differentiated by their antibiotic resistance property since the El Tor strains used were resistant to nalidixic acid, and the classical strains used were resistant to tetracycline or streptomycin. For phage positive samples, the presence of phage and the possible emergence of phage resistant derivatives of the classical V. cholerae strains was also monitored as described previously (17).
Transposon mutagenesis: Transposon mutagenesis was conducted to create mutants of phage susceptible V. cholerae strains that became phage resistant. Mutation was done by mobilizing transposon pSC137 from the donor strain E. coli SM10[[lambda].sub.pir] to the recipient strain by mating using previously described methods (18). The mutants were screened for susceptibility to JSF9 phage to select mutants that became phage resistant.
General properties of JSF9 phage: The JSF9 phage was initially isolated from a sample of river water collected in Dhaka city, but are commonly found in different environmental water samples. The phage produced clear plaques with a diameter of approximately 1 mm on lawns of classical biotype V. cholerae O1 strains. When grown in LB with a classical biotype strain S224, the phage produced in the culture supernatant had a titre of [~10.sup.8] pfu/ml. The specificity of the phage was examined using a panel of bacterial strains belonging to different Vibrio species or serogroups. Strains belonging to the classical biotype of V. cholerae O1 (Table I) were susceptible to the phage, whereas all other strains tested were clearly resistant.
We further examined whether the resistance of different V. cholerae strains to JSF9 phage was due to possible lysogeny of the phage in these strains, causing the bacteria to become immune to further infection by JSF9 phage. All strains listed in Table I, were probed with JSF9 phage DNA in colony blot hybridization. However, none of the strains tested were found to carry the JSF9 phage genome (data not shown).
Electron microscopic examination of JSF9 phage (Fig. 1) revealed that the phage particle comprised of a hexagonal head (~45 nm) and a short tail (~5 nm), and thus morphologically belonged to the family Podoviridae (19). The genome of JSF9 phage consisted of a ~41 kb double stranded DNA. The phage was highly stable (75 to 95%) in a pH range between 3.0 and 9.0, and at temperatures below 37oC. At temperatures above 50[degrees]C, the phage particles were rapidly inactivated. JSF9 phage remained infectious for more than 10 wk when stored at room temperature in samples of filter-sterilized surface water samples collected in Dhaka. These findings suggested that JSF9 phage may persist in the aquatic environment as infectious particles and act on susceptible V. cholerae strains.
[FIGURE 1 OMITTED]
El Tor biotype strains out-compete classical strains in the presence of JSF9 phage: We conducted competition assays between pairs of El Tor and classical biotype strains (Table II) in the presence and absence of JSF9 phage. Assays were designed to reproduce likely conditions in environmental water and host intestinal milieu (infant mouse model) which pathogenic V. cholerae strains are presumed to experience in nature. In the absence of JSF9 phage, classical strains competed well and the cumulative competition index (CCI) of El Tor to classical strain at the end of two consecutive rounds of assays in mice ranged between 1.15 and 1.84 (Table II), suggesting a somewhat better fitness of the El Tor strains. However, the relative fitness of El Tor strains was drastically enhanced when JSF9 phage was present, and the CCI ranged between 4.61 x [10.sup.4] and 3.13 x [10.sup.5] for different pairs of strains. Thus, the El Tor strains competed at least 10,000 fold better than classical strains in the presence of JSF9 phage.
To analyze whether the increase in the competition index was due to a difference in the infectivity of the two biotypes in the presence of JSF9 phage, we determined the [ID.sub.50] of the strains, a dose at which 50 per cent of challenged mice would be infected. This was done by inoculating various dilutions of log phase cultures into groups of mice with or without JSF9 phage. The mean [ID.sub.50] of the two groups of strains were found to be similar in the absence of the phage. However, in the presence of JSF9 phage, the [ID.sub.50] of the classical strains were ~10 fold higher (data not shown).
JSF9 phage resistant derivatives of classical strains are defective in colonization: During the competition assays, spontaneous mutants of classical biotype strains resistant to JSF9 phage were detected. However, these mutants did not compete well with the El Tor biotype strains or the wild type classical strains in the mouse competition assay (Fig. 2). Additionally, transposon mutagenesis was conducted in two JSF9 phage susceptible classical V. cholerae strains S224 and O395, to obtain mutants that became phage resistant and the JSF9 phage did not form plaques on a lawn of the mutants. Chromosomal sequence analyses of the transposon insertion sites revealed that mutants of classical biotype strains which became resistant to JSF9 phage infection and were no longer able to adsorb phage particles carried insertions in phospholipid and lipopolysaccharide biosynthetic genes. The gene encoding glycerol 3-phosphate acyltransferase (GPAT) was most frequently hit (4 of 7 mutants characterized) among the phage resistant mutants, followed by the gene encoding UDP-glucose-4-epimerase (3 of 7 phage resistant mutants). These mutants showed similar defect in the mouse colonization assay (Fig. 2).
[FIGURE 2 OMITTED]
Genetic and ecological factors which led to the elimination of the classical biotype of V. cholerae and promoted the emergence of the El Tor biotype strains have not been adequately explained. The evolutionary fitness of pathogenic strains of V. cholerae are presumed to be enhanced by their ability to amplify in the human host (4). However, both classical and El Tor biotypes of V. cholerae O1 produce the major virulence factors responsible for human colonization and dissemination through diarrhoeal purge. Hence the evolutionary success of the 7th pandemic clone over the pre-existing 6th pandemic strains is likely to have been influenced by factors other than their virulence potential in humans.
Recent microarray based comparative genomics have led to the identification of two clusters of genes in the 7th pandemic El Tor strains, known as the Vibrio seventh pandemic islands (VSP-1 and VSP-2) (20). Although these genes have been speculated to have a role in environmental fitness of El Tor strains, the precise functions of the genes remains to be investigated. The inherent capability of El Tor biotype strains to resist acid production in carbohydrate metabolism has also been suggested to be a factor improving their fitness (10). Studies have demonstrated that phages can significantly contribute to the distribution and abundance of different clones of V. cholerae (2,11). The present study was designed to investigate whether JSF9 or similar phages might have contributed to the events that led to the replacement of the 6th pandemic classical strains by the 7th pandemic El Tor strains by a bactericidal selective process.
Pathogenic strains of V. cholerae are known to transit between two different habitats. These include the host intestinal milieu and the aquatic environment, and in both these habitats the bacteria encounter different adverse conditions. The assay system in which V. cholerae recovered from the intestines of mice pre-challenged with mixtures of the pathogens and the phage were inoculated into samples of environmental water, was designed to reproduce possible conditions under which the classical and El Tor strains might have competed for survival. Although in the absence of JSF9 phage, the classical biotype strains were able to compete with the El Tor biotype strains, the presence of JSF9 phage led the El Tor strains to out-compete the classical strains (Table II) suggesting clearly that JSF9 phage, in addition to possible other factors, could have markedly influenced the enrichment of El Tor strains and the elimination of classical strains.
Phage bacterial interactions appear to occur in both the aquatic environment and in the host intestine. Previous studies have shown that cholera victims excrete high titres of phage in their stools at a time that also correlates with the appearance of high concentrations of phage in nearby environmental waters (11). Since pathogenic V. cholerae can grow rapidly in the host intestine, the host contributes significantly to the phage amplification by providing substrates for phage growth. Thus, host susceptibility to V. cholerae can influence phage-mediated selection of particular clones that are killed by the same phage once encountered in the extra-host environment (2,11). However, if a bacterial clone (e.g., the El Tor 7th pandemic clone) is resistant to a phage that otherwise kills a competing clone (i.e., the classical biotype clone), then the ecological fitness of the former would triumph over the latter in any dynamic setting that amplifies both bacteria and phage, while supporting the killing of phage-susceptible clones. Such an environment clearly exists in cholera endemic areas such as Bangladesh (2,11). This strategy can result in elimination of the phage's substrate organism and in the end the phage as well, unless the phage has a secondary host. Perhaps this logic also explains the absence of many classical biotype specific phages in the Bangladesh environment, at the same time suggesting that JSF9 phage might have an alternative host.
The bacterial surface structure often used by phages as a receptor for adsorption to bacteria includes lipopolysaccharide O-antigen, outer membrane proteins, and pili. Since both classical and El Tor biotype strains share the same O1 antigen and most other surface structures, the ability of the El Tor strains to survive attack by JSF9 phage under conditions when classical strains are completely susceptible indicates that the receptor for JSF9 phage is probably absent from the El Tor strains, and this might have been the key to the selective emergence of the El Tor strain. It has been recognized previously that there are certain differences in the pattern of gene expression between the El Tor and classical biotypes of V. cholerae O1 (21).
Although this study did not precisely identify the receptor for JSF9 phage infection, the observation that mutation in genes for glycerol 3-phosphate acyltransferase and UDP-glucose-4-epimerase confer phage resistance indicates a possible role of the bacterial LPS in JSF9 phage susceptibility. Alternatively, an OMP whose assembly in the membrane depends on lipid synthesis may also have a role. For example, in an Escherichia coli strain which is defective in glycerol-3-phosphate acyltransferase, a marked decrease of insertion of the bacteriophage Lambda receptor LamB protein occurs into the outer membrane (22).
In conclusion, the results of this study suggest that the ability to resist predation by JSF9 or similar phages might have contributed to the evolutionary fitness of the V. cholerae El Tor biotype compared to that of the classical biotype both as a global cause of cholera and as an environmental organism.
Received June 14, 2010
This research was funded in part by the National Institutes of Health grants 2RO1-GM068851-5, and AI070963-01A1, under different sub-agreements between the Harvard Medical School, USA and the ICDDR,B, Bangladesh. The ICDDR,B is supported by countries and agencies which share its concern for the health problems of developing countries.
(1.) Brussow H, Canchaya C, Hardt WD. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 2004; 68: 560-602.
(2.) Waldor MK, Mekalanos JJ. Lysogenic conversion by a filamentous bacteriophage encoding cholera toxin. Science 1996; 272: 1910-4.
(3.) Faruque SM, Naser IB, Islam MJ, Faruque AS, Ghosh AN, Nair GB, et al. Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proc Natl Acad Sci USA 2005; 102: 1702-7.
(4.) Faruque SM, Albert MJ, Mekalanos JJ. Epidemiology, genetics and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev 1998; 62: 1301-14.
(5.) Kaper JB, Morris JG Jr, Levine MM. Cholera. Clin Microbiol Rev 1995; 8: 48-86.
(6.) Siddique AK, Nair GB, Alam M, Sack DA, Huq A, Nizam A, et al. El Tor cholera with severe disease : a new threat to Asia and beyond. Epidemiol Infect 2010; 138: 347-52.
(7.) Colwell RR, Spira WM. The ecology of Vibrio cholerae. In: Barua D, Greenough WB III, editors. Cholera. New York, USA: Plenum Medical Book Co; 1992. p. 107-27.
(8.) Faruque SM, Biswas K, Udden SM, Ahmad QS, Sack DA, Nair GB, et al. Transmissibility of cholera: in vivo-formed biofilms and their relationship to infectivity and persistence in the environment. Proc Natl Acad Sci USA 2006; 103: 6350-5.
(9.) Kirn TJ, Jude BA, Taylor RK. A colonization factor links Vibrio cholerae environmental survival and human infection. Nature 2005; 438: 863-6.
(10.) Yoon SS, Mekalanos JJ. 2, 3-Butanediol synthesis and the emergence of the Vibrio cholerae El Tor biotype. Infect Immun 2006; 74: 6547-56.
(11.) Faruque SM, Islam MJ, Ahmad QS, Faruque AS, Sack DA, Nair GB, et al. Self-limiting nature of seasonal cholera epidemics: role of host-mediated amplification of phage. Proc Natl Acad Sci USA 2005; 102: 6119-24.
(12.) Jensen MA, Faruque SM, Mekalanos JJ, Levin BR. Modeling the role of bacteriophage in the control of cholera outbreaks. Proc Natl Acad Sci USA 2006; 103: 4652-7.
(13.) Albert MJ, Bhuyan NA, Rahman A, Ghosh AN, Hultenby K, Weintraub A, et al. Phage specific for Vibrio cholerae O139 Bengal. J Clin Microbiol 1996; 34: 1843-5.
(14.) Monsur KA. A highly selective gelatin-taurocholate-tellurite medium for the isolation of Vibrio cholerae. Trans R Soc Trop Med Hyg 1961; 55: 440-2.
(15.) Butler SM, Nelson EJ, Chowdhury N, Faruque SM, Calderwood SB, Camilli A. Cholera stool bacteria repress chemotaxis to increase infectivity. Mol Microbiol 2006; 60: 417-26.
(16.) Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938; 27 : 493-7.
(17.) Zahid MSH, Udden SM, Faruque ASG, Calderwood SB, Mekalanos JJ, Faruque SM. Effect of phage on the infectivity of Vibrio cholerae and emergence of genetic variants. Infect Immun 2008; 76: 5266-73.
(18.) Chiang SL, Mekalanos JJ. Construction of a Vibrio cholerae vaccine candidate using Transposon delivery and FLP recombinase-mediated excision. Infect Immun 2000; 68: 6391-7
(19.) Ackermann HW. Bacteriophage taxonomy in 1987. Microbiol Sci 1987; 4: 214-8.
(20.) Dziejman M, Balon E, Boyd D, Fraser CM, Heidelberg JF, Mekalanos JJ. Comparative genomic analysis of Vibrio cholerae: genes that correlate with cholera endemic and pandemic disease. Proc Natl Acad Sci USA 2002; 99: 1556-61.
(21.) Beyhan S, Tischler AD, Camilli A, Yildiz, FH. Differences in gene expression between the classical and El Tor biotypes of Vibrio cholerae O1. Infect Immun 2006; 74: 3633-42.
(22.) Pages C, Lazdunski C, Lazdunski A. The receptor of bacteriophage Lambda: evidence for a biosynthesis dependent on lipid synthesis. Eur J Biochem 1982; 122: 381-6.
Reprint requests: Dr Shah M. Faruque, Molecular Genetics Laboratory, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka-1212, Bangladesh e-mail: email@example.com
M. Shamim Hasan Zahid *, Zaved Waise *, M. Kamruzzaman *, A.N. Ghosh **, G. Balakrish Nair **, S.A.M. Khairul Bashar (+) *, John J. Mekalanos (#) & Shah M. Faruque *, (+)
* Molecular Genetics Laboratory, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh, **National Institute of Cholera & Enteric Diseases, Kolkata, India,
(+) Department of Life Sciences, North South University, Dhaka, Bangladesh &
(#) Department of Microbiology & Molecular Genetics, Harvard Medical School, Boston, Massachusetts, USA
Table I. Susceptibility of different V. cholerae strains to infection by JSF9 phage Strain Description S224, O395, S262, S263, L355, V. cholerae O1 classical L396, L547, L362, B36921, biotype strains C19385, C19751, D19316, E14850, E14983, AE4727, AE2883, AE4731, AE7471, AE7485 C6706, 2924281, 2868921, V. cholerae O1 El Tor biotype 2868912, AF-1471, AL-30457, strains AM-33126, AN-32320, G-8747, G- 3669, AP-13543, AM-33122, MG- 116955, AN-24088, AO-29054, 2614, 3055, 112V214 C-0273, C-1771, C-0270 V. cholerae O139 strains V46, V51 V. cholerae O141 strains SSF3 (S-224, VC395-0087::TnFC) Derivative of classical biotype strain S224 with transposon insertion in gene encoding Glycerol 3-P- acyltransferase SSF4 (O395, VC395-0087::TnFC) Derivative of classical biotype strain O395 with transposon insertion in gene encoding Glycerol 3-P- acyltransferase SSF6 (S-224, VC395-0291::TnFC) Derivative of classical biotype strain S224 with transposon insertion in gene encoding UDP-glucose-4- epimerase Phage Strain sensitivity * S224, O395, S262, S263, L355, S L396, L547, L362, B36921, C19385, C19751, D19316, E14850, E14983, AE4727, AE2883, AE4731, AE7471, AE7485 C6706, 2924281, 2868921, R 2868912, AF-1471, AL-30457, AM-33126, AN-32320, G-8747, G- 3669, AP-13543, AM-33122, MG- 116955, AN-24088, AO-29054, 2614, 3055, 112V214 C-0273, C-1771, C-0270 R V46, V51 R SSF3 (S-224, VC395-0087::TnFC) R SSF4 (O395, VC395-0087::TnFC) R SSF6 (S-224, VC395-0291::TnFC) R * Equal number of phage (-8.1 x [10.sup.8]) were plated on different bacterial lawns. S, susceptible (plaque counts, 6.9 x [10.sup.8]--8.1 x [10.sup.8]); R, resistant (no plaques detected) Table II. Assays in microcosms and infant mice to model the effect of JSF9 phage on the emergence of the El Tor biotype and replacement of classical biotype of V. cholerae O1 Rounds of El Tor strain 2680370 assays Input count Output count (a) Round 1A 9.5 x [10.sup.5] 5.0 x [10.sup.7] Round 1B (b) 3.8 x [10.sup.5] 1.2 x [10.sup.7] Round 2A 9.2 x [10.sup.5] 1.0 x [10.sup.8] Round 2B (b) 6.0 x [10.sup.5] 3.7 x [10.sup.7] Rounds of Classical strain O395 assays Input count Output count (a) Round 1A 1.2 x [10.sup.6] 3.1 x [10.sup.7] Round 1B (b) 2.0 x [10.sup.5] 8.2 x [10.sup.6] Round 2A 1.1 x [10.sup.6] 8.9 x [10.sup.5] Round 2B (b) 2.0 x [10.sup.3] 5.0 x [10.sup.2] Rounds of Phage JSF9 assays Input count Output count (a) Round 1A 0 0 Round 1B (b) 0 0 Round 2A 7.8 x [10.sup.7] 6.0 x [10.sup.7] Round 2B (b) 7.8 x [10.sup.5] 6.5 x [10.sup.6] Rounds of Cumulative assays competition index (c) Round 1A 1.84 Round 1B (b) Round 2A 8.85 x [10.sup.4] Round 2B (b) Rounds of El Tor strain 2706062 assays Input count Output count (a) Round 3A 7.3 x [10.sup.5] 2.2 x [10.sup.7] Round 3B (b) 4.0 x [10.sup.4] 6.3 x [10.sup.6] Round 4A 6.8 x [10.sup.5] 3.4 x [10.sup.7] Round 4B (b) 8.2 x [10.sup.5] 2.6 x [10.sup.7] Rounds of Classical strain AE7471 assays Input count Output count (a) Round 3A 3.2 x [10.sup.5] 2.6 x [10.sup.6] Round 3B (b) 8.0 x [10.sup.4] 2.4 x [10.sup.6] Round 4A 6.5 x [10.sup.5] 4.8 x [10.sup.5] Round 4B (b) 1.0 x [10.sup.3] 5.4 x [10.sup.2] Rounds of Phage JSF9 assays Input count Output count (a) Round 3A 0 0 Round 3B (b) 0 0 Round 4A 7.0 x [10.sup.7] 7.5 x [10.sup.7] Round 4B (b) 3.2 x [10.sup.5] 1.0 x [10.sup.6] Rounds of Cumulative assays competition index (c) Round 3A 1.15 Round 3B (b) Round 4A 4.61 x [10.sup.4] Round 4B (b) Rounds of El Tor strain 2680335 assays Input count Output count (a) Round 5A 6.0 x [10.sup.5] 5.5 x [10.sup.6] Round 5B (b) 7.8 x [10.sup.4] 4.1 x [10.sup.6] Round 6A 6.0 x [10.sup.5] 1.5 x [10.sup.7] Round 6B (b) 8.0 x [10.sup.4] 8.3 x [10.sup.6] Rounds of Classical strain AE2883 assays Input count Output count (a) Round 5A 5.6 x [10.sup.5] 2.7 x [10.sup.6] Round 5B (b) 4.8 x [10.sup.4] 2.2 x [10.sup.6] Round 6A 6.8 x [10.sup.5] 8.9 x [10.sup.5] Round 6B (b) 7.0 x [10.sup.3] 3.0 x 10 Rounds of Phage JSF9 assays Input count Output count (a) Round 5A 0 0 Round 5B (b) 0 0 Round 6A 9.0 x [10.sup.7] 8.1 x [10.sup.7] Round 6B (b) 9.0 x [10.sup.5] 5.0 x [10.sup.5] Rounds of Cumulative assays competition index (c) Round 5A 1.73 Round 5B (b) Round 6A 3.13 x [10.sup.5] Round 6B (b) (a) Concentration of V. cholerae cells and phage in the intestinal contents of mice challenged with a mixture of an El Tor and a classical strain with or without phage JSF9. Values represent the mean of 5 observations; (b) Intestinal contents of mice from round-A of the assay was inoculated into aliquots of filter-sterilized environmental water and incubated for 6 h. In round-B of the assay mice were inoculated with fractions of this water. All classical strains isolated from mice after both rounds remained sensitive to JSF9; (c) For calculation of cumulative competition index for each set of assay the ratio of output counts of El Tor strain to classical strain in round-B was divided by the ratio of input counts of El Tor strain to classical strain in round-A
|Printer friendly Cite/link Email Feedback|
|Author:||Zahid, M. Shamim Hasan; Waise, Zaved; Kamruzzaman, M.; Ghosh, A.N.; Nair, G. Balakrish; Bashar, S.A.|
|Publication:||Indian Journal of Medical Research|
|Date:||Feb 1, 2011|
|Previous Article:||Genetic components of stringent response in Vibrio cholerae.|
|Next Article:||Antimicrobials & cholera: are we stranded?|